Answers are grounded in this paper and cite their sources.
The discovery of polypeptide mitogens capable of stimulating angiogenesis has inspired research addressing the potential of these agents in the treatment of ischaemic syndromes. Ischaemia or necrosis with associated inflammation has been found to increase the production of growth factors and receptor response. Administration of various exogenous angiogenic agents by several routes has resulted in enhanced growth of collateral vessels in animal models of myocardial, peripheral arterial, and cerebral insufficiency. Therapeutic angiogenesis may have an immense clinical potential.
No takes yet. Share an insight, caveat, or question.
Symes et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: